Which SSRIs Cause Low Blood Pressure
All SSRIs can cause postural hypotension, with the highest risk occurring in the first 28 days of treatment, particularly in adults over 60 years old. Among SSRIs, the evidence suggests they collectively pose a greater risk for orthostatic hypotension than previously recognized, with SSRIs showing a 4-fold increased risk compared to baseline in older adults 1.
Risk Profile by SSRI Class
The most recent and highest quality evidence demonstrates that SSRIs as a class carry the highest risk for postural hypotension compared to other antidepressants (incidence rate ratio 4.22 in the first 28 days), exceeding both tricyclic antidepressants (IRR 2.12) and other antidepressants (IRR 2.17) 1. This 2025 study of over 41,000 older adults provides the strongest evidence available.
Specific SSRIs Implicated:
- Fluvoxamine and paroxetine were specifically documented causing orthostatic hypotension and first-degree AV block in hospitalized patients 2
- All SSRIs studied (fluoxetine, paroxetine, sertraline) caused significant reductions in sympathetic nerve activity (-31% to -59%), which mechanistically explains the hypotensive effects 3
Critical Time Windows
The risk is dramatically elevated in days 1-28 after initiation, then substantially decreases after day 28 1. This temporal pattern is crucial for monitoring:
- Days 1-28: Peak risk period requiring close blood pressure monitoring
- Days 29-56: Declining but still elevated risk
- Day 57+: Risk approaches baseline
High-Risk Scenarios
Elderly Patients (≥60 years)
The evidence is unequivocal that older adults face substantially higher risk 1. Monitor blood pressure at baseline and within the first 2 weeks of initiation in all patients over 60.
Combination Therapy
Adding even small doses of tricyclic antidepressants to SSRIs can cause remarkably severe hypotension, particularly in elderly patients 4. This combination should be avoided or used with extreme caution and close monitoring.
Mechanism
SSRIs cause sympathoinhibition (reduction in sympathetic nervous system activity), which begins within 5 minutes of administration and lasts approximately 30 minutes per dose 3. This explains the orthostatic component—patients lack adequate sympathetic compensation when standing.
Clinical Monitoring Algorithm
- Baseline assessment: Measure supine and standing blood pressure before initiating any SSRI in patients ≥60 years
- Week 1-2: Recheck orthostatic vital signs
- Week 4: Final assessment if stable
- Educate patients about symptoms of orthostatic hypotension (dizziness, lightheadedness upon standing)
- Avoid TCA combinations unless absolutely necessary with intensive monitoring
Important Caveats
While the 2008 ACP guideline recommends selecting SSRIs based on adverse effect profiles 5, it does not specifically address hypotension—likely because this risk was underappreciated at that time. The guideline's focus on sexual dysfunction and suicidality as primary adverse effects predates the robust 2025 evidence on postural hypotension 1.
The evidence contradicts older assumptions that SSRIs are cardiovascularly neutral. One study even showed SSRIs reduced intraoperative hypotension 6, but this controlled surgical setting doesn't reflect real-world orthostatic challenges in ambulatory elderly patients.